Opioids Still Needed by Some Pain Patients

The "other victims" of the opioid epidemic are pain patients who need the drugs but cannot now get them because of fears related to their use

 

Getty Images/iStockphoto/Thinkstock Images

Illustration of a Bohr atom model spinning around the words Science Quickly with various science and medicine related icons around the text

Join Our Community of Science Lovers!

“The opioid epidemic is a national crisis that should not be underestimated.” That’s a quote from a June 1st New England Journal of Medicine perspective piece by Susan Glod. She’s a physician involved with hospice and palliative care and pain management. But the title of the piece reveals another issue related to the current situation. That title is The Other Victims of the Opioid Epidemic. Those other victims being people in desperate need of pain treatment who cannot now get it because of fears related to the prescribing and use of opioids.

To try to help to avoid abuse, new forms of opioids have been created, called abuse-deterrent opioid medications. These can’t be crushed or dissolved, thus making them difficult to snort or inject. But “these formulations would have no impact on other opioid-related deaths such as unintentional overdose.”

Glod in an audio interview related to her New England Journal piece.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


“I think that the downside to all of these formulations is that they have the potential to make needed medication more expensive and less accessible to patients who are having opioid responsive pain and who really do require these medications. What really worries me the most about all of this is that if the medical community, the public and policy makers get too distracted by the promise of a solution to the opioid epidemic in the guise of a reformulation of known opioids, I’m worried that we’re going to lose focus on addressing all of the underlying systemic issues that have really led to the epidemic in the first place—such as lack of access to alternative evidence-based means of controlling pain, the lack of mental health and social services to address other components of suffering besides physical pain, and the lack of providers who are trained in managing drug addiction and dependence.”

Glod’s full article and audio interview are available at the website of the New England Journal of Medicine.

—Steve Mirsky

[The above text is a transcript of this podcast.]

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe